Liver cancer is the second most common cancer with a high mortality rate worldwide. According to WHO, liver cancer is the fifth most common cancer in men and seventh most common cancer in women. Treatment could be possible only if diagnosed at an early stage. Hence research studies were conducted worldwide to find the most accurate diagnostic tool to detect liver cancer.
The problem with the common cold is that it isn’t just one virus. It’s a family of viruses that evolve so quickly no one can ever be fully immune to the cold, and developing a vaccine that can tackle all of the variations of the virus is impossible. But what if there were one way to block the ability of all cold viruses from replicating—thereby fending off the sneezing, sore throat and general misery that they cause?
Prosecutors have already charged Insys founder John Kapoor and won guilty pleas from two characters in an ongoing kickbacks probe. Now, the Justice Department has escalated the case by joining in with whistleblowers who've detailed a stunning range of techniques the company allegedly used to push its powerful opioid painkiller.
The FDA granted approval to Pfizer for Retacrit (epoetin alfa-epbx), which is used for the treatment of anemia, biosimilar of Amgen, a drug which generated sales closely $ 1.8 billion in the U.S market last year for Amgen and Johnson & Johnson partners. Retacrit also received the go-ahead to be used in RBC transfusions by U.S health regulators.
As America’s population ages, a 4 billion USD opportunity is being foreseen by Thomas DeRosa for changing the U.S. health infrastructure through instituting a low-cost healthcare network and disrupting conventional healthcare practices.
Providing an advanced technological paradigm to patient monitoring practices, a telemedicine platform has been launched in Australia. The remote intensive care partnership will enable doctors and nurses at the Royal Perth Hospital on the western coast of Australia to explore telemedicine technology to assess patient health in US hospitals that form part of the hub-and-spoke telehealth network of Emory.
When it comes to manufacturing CAR T drugs (personalized treatments engineering immune cells to destroy cancer cells of patients) speed is of utmost importance. A new manufacturing site has been decided upon by Gilead for Yescarta, its CAR-T therapy at a Netherlands airport.
Serious security flaws were discovered in Philips, GE and Silex medical devices that, if exploited, could allow authorized access and let a hacker obtain elevated privileges, according to two separate U.S. Department of Homeland Security ICS-CERT alerts issued this month.
A clinical trial solution has been unveiled by DNAnexus that facilitates the integration of genomics data sourced from next-generation sequencing (NGS) into clinical studies. A cloud-based genomic data collection platform is offered by DNAnexus.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.